🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study was to evaluate the reactogenicity, safety and im...
Status
Completed
Location
GSK Investigational Site
Start Date
2022-02-02
Trial ID
NCT05169905
Treatments Being Tested
The purpose of this study was to evaluate the safety, reactogenicity and im...
Status
Terminated
Location
GSK Investigational Site
Start Date
2021-08-03
Trial ID
NCT04980391
The purpose of this follow-up study was to describe the safety in subsequen...
Status
Completed
Location
GSK Investigational Site
Start Date
2023-02-07
Trial ID
NCT05705440
Treatments Being Tested
The purpose of this study was to evaluate the safety and immune response to...
Status
Completed
Location
GSK Investigational Site
Start Date
2019-11-05
Trial ID
NCT04126213
Treatments Being Tested
The purpose of this study is to evaluate the clinical lot-to-lot consistenc...
Status
Completed
Location
GSK Investigational Site
Start Date
2021-10-26
Trial ID
NCT05045144
Treatments Being Tested
The purpose of this study was to evaluate the ability of a single dose of t...
Status
Terminated
Location
GSK Investigational Site
Start Date
2020-11-20
Trial ID
NCT04605159
The purpose of this study is to evaluate the safety, reactogenicity and imm...
Status
Withdrawn
Location
GSK Investigational Site
Start Date
2022-03-11
Trial ID
NCT05229068
Treatments Being Tested
The purpose of this study is to evaluate different dose levels of the inves...
Status
Completed
Location
GSK Investigational Site
Start Date
2018-10-30
Trial ID
NCT03674177